Time trends of cardiovascular disease in the general population and inflammatory arthritis

A Södergren… - Rheumatic Disease …, 2023 - rheumatic.theclinics.com
Background Cardiovascular diseases (CVDs) have long been recognized as the leading
causes of death in the world. Most of these CV deaths are attributable to either ischemic …

Polypharmacy among older individuals with heart failure: Trends between 2000 and 2017 in the province of Quebec, Canada

A Campeau Calfat, M Simard, A Ouali… - Therapeutic …, 2022 - journals.sagepub.com
Objective: Pharmacological management of heart failure and comorbidities may result in
polypharmacy, but there are few population-based studies that portray the use of …

Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study

N Vinter, P Cordsen, M Fenger-Grøn… - … Journal-Quality of …, 2022 - academic.oup.com
Aims Incident atrial fibrillation (AF) is an adverse prognostic indicator in heart failure (HF);
identifying modifiable targets may be relevant to reduce the incidence and morbidity of AF …

Pesquisa translacional e medicamentos: tempo decorrido entre o desenvolvimento clínico ea dispensação no SUS, e seus fatores associados

EO Lupatini - 2022 - realp.unb.br
Introdução: A demora em disponibilizar medicamentos comprovadamente seguros, eficazes
e custo-efetivos tende a reduzir os ganhos de saúde da população. Assim, identificar os …

Polypharmacie chez les aînés atteints d'insuffisance cardiaque: portrait des tendances entre 2000 et 2017 dans la province de Québec, Canada.

A Campeau Calfat - 2021 - corpus.ulaval.ca
Résumé Contexte: La prise en charge de l'insuffisance cardiaque et des comorbidités
associées chez un individu peut mener à l'utilisation d'un grand nombre de médicaments, la …